Premium
Circular RNAs in metabolism and metabolic disorders
Author(s) -
Zeng Yongzhi,
Zheng Zhi,
Liu Fengtao,
Yi Guanghui
Publication year - 2021
Publication title -
obesity reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.845
H-Index - 162
eISSN - 1467-789X
pISSN - 1467-7881
DOI - 10.1111/obr.13220
Subject(s) - dyslipidemia , disease , metabolic syndrome , biology , bioinformatics , metabolic pathway , glucose homeostasis , lipid metabolism , adipose tissue , type 2 diabetes mellitus , homeostasis , circular rna , diabetes mellitus , medicine , metabolism , endocrinology , microrna , insulin resistance , genetics , gene
Summary Metabolic syndrome (MetS) is a serious health condition triggered by hyperglycemia, dyslipidemia, and abnormal adipose deposition. Recently, circular RNAs (circRNAs) have been proposed as key molecular players in metabolic homeostasis due to their regulatory effects on genes linked to the modulation of multiple aspects of metabolism, including glucose and lipid homeostasis. Dysregulation of circRNAs can lead to metabolic disorders, indicating that circRNAs represent plausible potential targets to alleviate metabolic abnormalities. More recently, a series of circulating circRNAs have been identified to act as both essential regulatory molecules and biomarkers for the progression of metabolism‐related disorders, including type 2 diabetes mellitus (T2DM or T2D) and cardiovascular disease (CVD). The findings of this study highlight the function of circRNAs in signaling pathways implicated in metabolic diseases and their potential as future therapeutics and disease biomarkers.